CGEM
Price
$15.80
Change
+$0.88 (+5.89%)
Updated
Nov 3, 03:56 PM (EDT)
Capitalization
960.82M
2 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$17.62
Change
+$0.34 (+1.97%)
Updated
Nov 3, 04:10 PM (EDT)
Capitalization
3.79B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEM vs RLAY

CGEM vs RLAY Comparison Chart in %
View a ticker or compare two or three
VS
CGEM vs. RLAY commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and RLAY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CGEM with price predictions
Nov 02, 2026

CGEM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 16, 2026

CGEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 30 of 35 cases where CGEM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CGEM's RSI Indicator exited the oversold zone, 21 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on CGEM as a result. In 74 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for CGEM just turned positive on October 20, 2026. Looking at past instances where CGEM's MACD turned positive, the stock continued to rise in 41 of 52 cases over the following month. The odds of a continued upward trend are 79%.

Following a +7.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEM advanced for three days, in 205 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 57 cases where CGEM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for CGEM entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.986) is normal, around the industry mean (3.104). P/E Ratio (-4.801) is within average values for comparable stocks, (-0.958). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.907) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (439.647).

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CGEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for RLAY with price predictions
Nov 02, 2026

Momentum Indicator for RLAY turns positive, indicating new upward trend

RLAY saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 82 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RLAY just turned positive on October 21, 2026. Looking at past instances where RLAY's MACD turned positive, the stock continued to rise in 36 of 41 cases over the following month. The odds of a continued upward trend are 88%.

The 10-day moving average for RLAY crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +8.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where RLAY advanced for three days, in 236 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 52 cases where RLAY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.

RLAY moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

RLAY broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RLAY entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.255) is normal, around the industry mean (3.104). P/E Ratio (-11.077) is within average values for comparable stocks, (-0.958). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (129.907) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (439.647).

The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. RLAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CGEM vs RLAY: Fundamental Ratings
CGEM
RLAY
OUTLOOK RATING
1..100
2865
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4237
P/E GROWTH RATING
1..100
2633
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RLAY's Valuation (25) in the null industry is in the same range as CGEM (33). This means that RLAY’s stock grew similarly to CGEM’s over the last 12 months.

RLAY's Profit vs Risk Rating (100) in the null industry is in the same range as CGEM (100). This means that RLAY’s stock grew similarly to CGEM’s over the last 12 months.

RLAY's SMR Rating (97) in the null industry is in the same range as CGEM (98). This means that RLAY’s stock grew similarly to CGEM’s over the last 12 months.

RLAY's Price Growth Rating (37) in the null industry is in the same range as CGEM (42). This means that RLAY’s stock grew similarly to CGEM’s over the last 12 months.

CGEM's P/E Growth Rating (26) in the null industry is in the same range as RLAY (33). This means that CGEM’s stock grew similarly to RLAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGEMRLAY
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (CGEM: $14.93 vs. RLAY: $17.28)
Brand notoriety: CGEM and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 81% vs. RLAY: 109%
Market capitalization -- CGEM: $960.82M vs. RLAY: $3.79B
CGEM [@Biotechnology] is valued at $960.82M. RLAY’s [@Biotechnology] market capitalization is $3.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $140.2B. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 2 FA rating(s) are green while RLAY’s FA Score has 2 green FA rating(s).

  • CGEM’s FA Score: 2 green, 3 red.
  • RLAY’s FA Score: 2 green, 3 red.
According to our system of comparison, both CGEM and RLAY are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • CGEM’s TA Score: 5 bullish, 3 bearish.
  • RLAY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than RLAY.

Price Growth

CGEM (@Biotechnology) experienced а +2.68% price change this week, while RLAY (@Biotechnology) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.94%. For the same industry, the average monthly price growth was -11.98%, and the average quarterly price growth was -17.06%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 05, 2026.

RLAY is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CGEM
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with CABA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-0.67%
CABA - CGEM
49%
Loosely correlated
-5.30%
LXEO - CGEM
47%
Loosely correlated
-2.55%
RCKT - CGEM
47%
Loosely correlated
+1.23%
RLAY - CGEM
46%
Loosely correlated
-5.83%
PRME - CGEM
46%
Loosely correlated
-5.93%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with KURA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-5.83%
KURA - RLAY
48%
Loosely correlated
-4.58%
CGEM - RLAY
47%
Loosely correlated
-0.67%
SNDX - RLAY
46%
Loosely correlated
-4.03%
VCYT - RLAY
44%
Loosely correlated
-2.02%
LXEO - RLAY
43%
Loosely correlated
-2.55%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPG124.895.37
+4.49%
PPG Industries
FDUS19.480.17
+0.88%
Fidus Investment Corp
GEO27.89-0.63
-2.21%
GEO Group (The)
TURB0.81-0.04
-4.61%
Turbo Energy SA
TONX2.91-0.15
-4.90%
TON Strategy Company